IR-PERPUSTAKAAN UNIVERSITAS AIRLANGGA

DAFTAR PUSTAKA

Aisyah, S., Hasneli, Y., & Sabrian, F. (2018). Hubungan Antara Dukungan
Keluarga dengan Kontrol Gula Darah dan Olahraga pada Penderita Diabetes
Melitus. Jurnal Online Mahasiswa FKp, 5(2), 211–221.

Al-Shukaili, A., AL-Ghafri, S., Al-Marhoobi, S., Al-Abri, S., Al-Lawati, J., & Al-
Maskari, M. (2013). Analysis of Inflammatory Mediators in Type 2 Diabetes
Patients. International Journal of Endocrinology, 2013, 1–7.
https://doi.org/10.1155/2013/976810

Badawi, A. (2016). Type 2 diabetes mellitus and inflammation: Prospects for

biomarkers of risk and nutritional intervention. Diabetes, Metabolic
Syndrome and Obesity: Targets and Therapy, Volume 3, 173–186.
https://doi.org/10.2147/dmso.s9089

Banerjee, M. (2014). Genetic polymorphisms of cytokine genes in type 2 diabetes

mellitus. World Journal of Diabetes, 5(4), 493.
https://doi.org/10.4239/wjd.v5.i4.493

Burhans, M. S., Hagman, D. K., Kuzma, J. N., Schmidt, K. A., & Kratz, M.
(2019). Contribution of Adipose Tissue Inflammation to the Development of
Type 2 Diabetes Mellitus. Comprehensive Physiology, 9(1), 1–58.
https://doi.org/10.1002/cphy.c170040

Faisal, M. (2018). Hubungan Kadar Small Dense LDL dengan Derajat Retinopati
Diabetika pada Pasien Diabetes Mellitus Tipe 2. Repositori Institusi USU.

Firdaus, E. A. (2014). Efek Ekstrak Kayu Manis (Cinnamomum casia) Terhadap

Kadar Glukosa Darah, Berat Badan, dan Kolesterol Pada Tikus Jantan Strain
Sparague yang Diinduksi Aloksan dawley.

Funciona, N. (2015). Continual evolution of type 2 diabetes: an update on

pathophysiology and emerging treatment options. Therapeutics and Clinical
Risk Management, 11, 621. https://doi.org/10.2147/TCRM.S67387

Garbers, C., Heink, S., Korn, T., & Rose-John, S. (2018). Interleukin-6:
Designing specific therapeutics for a complex cytokine. Nature Reviews
Drug Discovery, 17(6), 395–412. https://doi.org/10.1038/nrd.2018.45

Hajer, G. R., Van Haeften, T. W., & Visseren, F. L. J. (2008). Adipose tissue
dysfunction in obesity, diabetes, and vascular diseases. European Heart
Journal, 29(24), 2959–2971. https://doi.org/10.1093/eurheartj/ehn387

Hildreth, C. J. (2008). Inflammation and Diabetes. Jama, 300(21), 2476.

https://doi.org/10.1001/jama.2008.737

Huang, Y. C., Chang, P. Y., Hwang, J. S., & Ning, H. C. (2014). Association of
small dense low-density lipoprotein cholesterol in type 2 diabetics with

TESIS HUBUNGAN KADAR INTERLEUKIN 6 SUARDI

 IR-PERPUSTAKAAN UNIVERSITAS AIRLANGGA

coronary artery disease. Biomedical Journal, 37(6), 375–379.

https://doi.org/10.4103/2319-4170.132883

Hunter, C. A., & Jones, S. A. (2015). IL-6 as a keystone cytokine in health and
disease. Nature Immunology, 16(5), 448–457. https://doi.org/10.1038/ni.3153

Jones, S. A., & Jenkins, B. J. (2018). Recent insights into targeting the IL-6
cytokine family in inflammatory diseases and cancer. Nature Reviews
Immunology, 18(12), 773–789. https://doi.org/10.1038/s41577-018-0066-7

Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016). Sex and gender differences
in risk, pathophysiology and complications of type 2 diabetes mellitus.
Endocrine Reviews, 37(3), 278–316. https://doi.org/10.1210/er.2015-1137

Ma, Q., Li, Y., Wang, M., Tang, Z., Wang, T., Liu, C., … Zhao, B. (2018).
Progress in Metabonomics of Type 2 Diabetes Mellitus. Molecules, 23(7),
1834. https://doi.org/10.3390/molecules23071834

Mooradian, A. (2008). No Title. Nature Clinical Practice, 05.

https://doi.org/doi:10.1038/ncpendmet1066

Nazari, A., Sardoo, A. M., & Fard, E. T. (2017). Is IL-6 Increased in Type 2
Diabetes Mellitus Patients Independent of Nephropathic Complication ?, 5,
10–12.

Nwaneri, C. (2015). Diabetes mellitus : a complete ancient and modern historical

perspective. WebmedCentral Diabetes, 6(2), 1–28.
https://doi.org/10.9754/journal.wmc.2015.004831

Okur, M. E., Karantas, I. D., & Siafaka, P. I. (2017). Diabetes mellitus: A review
on pathophysiology, current status of oral medications and future
perspectives. Acta Pharmaceutica Sciencia, 55(1), 61–82.
https://doi.org/10.23893/1307-2080.APS.0555

PERKENI. (2015). Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2.

Jakarta : Penrbit Buku PERKENI.

Riskesdas. (2018). Hasil Utama Riskesdas Tentang Prevalensi Diabetes Mellitus

di Indonesia 2018. https://doi.org/1 Desember 2013

Saad, S., & Zghebi, M. (2016). Epidemiology and Multimorbidity of Type 2

Diabetes and the Risk of Major Cardiovascular Events A thesis submitted to
the University of Manchester for the degree of Doctor of Philosophy in the
Faculty of Biology , Medicine and Health Salwa Saad M Zghebi Sc.
Retrieved from
https://www.research.manchester.ac.uk/portal/files/56365243/FULL_TEXT.
PDF

Shih, Y., Ho, K., Tsao, C., Chang, Y., & Shiau, M. (2013). Role of Cyotkines in
Metabolism and Type 2 Diabetes Mellitus, (1), 1–6.

TESIS HUBUNGAN KADAR INTERLEUKIN 6 SUARDI

 IR-PERPUSTAKAAN UNIVERSITAS AIRLANGGA

Srisawasdi, P., Chaloeysup, S., Teerajetgul, Y., Pocathikorn, A., Sukasem, C.,
Vanavanan, S., & Kroll, M. H. (2011). Estimation of plasma small dense
LDL cholesterol from classic lipid measures. American Journal of Clinical
Pathology, 136(1), 20–29. https://doi.org/10.1309/AJCPLHJBGG9L3ILS

Suh, S., Park, H. D., Kim, S. W., Bae, J. C., Tan, A. H. K., Chung, H. S., … Lee,
M. K. (2011). Smaller Mean LDL particle size and higher proportion of
small dense LDL in Korean type 2 diabetic patients. Diabetes and
Metabolism Journal, 35(5), 536–542.
https://doi.org/10.4093/dmj.2011.35.5.536

Yuniarti, E., Syamsurizal, S., Ahda, Y., & Sonata, P. D. (2018). Correlation of
Fasting Blood Glucose With IL-6 Levels in Type-2 Diabetes Mellitus Ethnic
Minangkabau. Bioscience, 2(1), 11. https://doi.org/10.24036/02018219858-
0-00

Zheng, Y., Ley, S. H., & Hu, F. B. (2018). Global aetiology and epidemiology of
type 2 diabetes mellitus and its complications. Nature Reviews
Endocrinology, 14(2), 88–98. https://doi.org/10.1038/nrendo.2017.151

TESIS HUBUNGAN KADAR INTERLEUKIN 6 SUARDI